Provided by Tiger Trade Technology Pte. Ltd.

ACADIA Pharmaceuticals

21.56
-0.1600-0.74%
Post-market: 21.13-0.4300-1.99%17:14 EDT
Volume:807.26K
Turnover:17.44M
Market Cap:3.68B
PE:9.82
High:21.96
Open:21.71
Low:21.45
Close:21.72
52wk High:28.35
52wk Low:19.69
Shares:170.49M
Float Shares:115.85M
Volume Ratio:0.62
T/O Rate:0.70%
Dividend:- -
Dividend Rate:- -
EPS(TTM):2.20
EPS(LYR):2.30
ROE:37.32%
ROA:3.69%
PB:2.95
PE(LYR):9.37

Loading ...

ACADIA Pharmaceuticals shareholders approved 5.21 million-share increase to 2024 equity plan

Reuters
·
May 30

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Cardiff Oncology (CRDF), ACADIA Pharmaceuticals (ACAD) and Immunic (IMUX)

TIPRANKS
·
May 22

Assessing ACADIA Pharmaceuticals (ACAD) Valuation After Pipeline Progress And Product Rollouts

Simply Wall St.
·
May 21

A Look At ACADIA Pharmaceuticals (ACAD) Valuation After Mixed Q1 2026 Results And EU Trofinetide Setback

Simply Wall St.
·
May 11

ACADIA Pharmaceuticals Is Maintained at Buy by Citigroup

Dow Jones
·
May 09

ACADIA Pharmaceuticals Signals Confident Path After Q1 Call

TIPRANKS
·
May 08

Analysts Have Conflicting Sentiments on These Healthcare Companies: Evotec AG (EVO), Vaxcyte (PCVX) and ACADIA Pharmaceuticals (ACAD)

TIPRANKS
·
May 08

RBC Capital Sticks to Their Buy Rating for ACADIA Pharmaceuticals (ACAD)

TIPRANKS
·
May 07

Analysts Offer Insights on Healthcare Companies: Kissei Pharmaceutical Co (OtherKSPHF), Recursion Pharmaceuticals (RXRX) and ACADIA Pharmaceuticals (ACAD)

TIPRANKS
·
May 07

Analysts Conflicted on These Healthcare Names: ACADIA Pharmaceuticals (ACAD), Qiagen (QGEN) and Alcon (ALC)

TIPRANKS
·
May 07

Acadia Pharmaceuticals Q1 revenue rises on DAYBUE growth

Reuters
·
May 07

ACADIA Pharmaceuticals Q1 EPS $0.02 Misses $0.05 Estimate, Sales $268.062M Miss $280.710M Estimate

Benzinga
·
May 07

BRIEF-Acadia Pharmaceuticals Q1 EPS USD 0.02

Reuters
·
May 07

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
May 06

A Look At ACADIA Pharmaceuticals (ACAD) Valuation As Recent Returns Send Mixed Signals

Simply Wall St.
·
May 02

Acadia R&D chief Elizabeth Thompson to retire, company launches successor search

Reuters
·
May 01

ACADIA Pharmaceuticals Announces Planned Year-End Retirement of Elizabeth H.z. Thompson, Ph.d., Head of Research and Development, Following a Distinguished Career

THOMSON REUTERS
·
May 01

Earning Preview: ACADIA Pharmaceuticals this quarter’s revenue is expected to increase by 17.56%, and institutional views are bullish

Earnings Agent
·
Apr 30

Acadia Pharmaceuticals announces virtual annual shareholder meeting

Reuters
·
Apr 29

ACADIA Pharmaceuticals publishes 2025 annual report

Reuters
·
Apr 29